PROGNOSIS OF GERIATRIC COVID-19 PATIENTS ADMITTED TO INTENSIVE CARE UNIT ACCORDING TO VACCINATION STATUS

Basit Öğe Kaydı
dc.authoridÖterkuş, Mesut/0000-0003-1025-7662
dc.authoridAydin, Ahmet/0000-0003-1836-2061
dc.authoridKasapoglu, Umut Sabri/0000-0003-2869-9872
dc.authoridkaçmaz, osman/0000-0002-1219-7758
dc.authoridKOCA, ERDINC/0000-0002-6691-6711
dc.authorwosidÖterkuş, Mesut/AAP-4965-2020
dc.authorwosidAydin, Ahmet/AAC-4014-2022
dc.authorwosidKasapoglu, Umut Sabri/F-1786-2019
dc.authorwosidkaçmaz, osman/GXG-6745-2022
dc.authorwosidKOCA, ERDINC/GSJ-0735-2022
dc.contributor.authorAydin, Ahmet
dc.contributor.authorKacmaz, Osman
dc.contributor.authorKoca, Erdinc
dc.contributor.authorKutlusoy, Sevgi
dc.contributor.authorKasapoglu, Umut Sabri
dc.contributor.authorOterkus, Mesut
dc.date.accessioned2024-08-04T21:00:55Z
dc.date.available2024-08-04T21:00:55Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIntroduction: As of June 27, 2022, the COVID-19 pandemic has caused over 540 million infections and 6.3 million deaths. We aimed to investigate the effect of the vaccine on the clinical course of elderly patients hospitalized in the intensive care unit and to determine the prognosis of the patients according to their vaccination status. Materials and Methods: The study included 157 patients over the age of 65. Patients were divided into two groups. The first group consisted of patients who were vaccinated with two doses of CoronaVac, and the second group consisted of patients who were not vaccinated. Demographic data of the patients, prehospital clinical frailty scales, Charlson Comorbidity Indexes, APACHE II scores, laboratory values, and patient prognoses were recorded. Results: Of the 157 patients, 93 (59.2%) were female, and the median age was 76 years (65-99). 96 (61.1%) patients were vaccinated and 61 (38.9%) patients were unvaccinated. Patients were grouped as survivors (n=26) and deceased. We found that APACHE II, prehospital clinical frailty scales, and Charlson Comorbidity Indexes scores were higher in patients who died. There was a significant difference between blood lymphocyte and ferritin levels and survival. The 28-day survival rate was higher and intensive care unit overall survival time were longer in the vaccinated group. Conclusions: We observed that the vaccinated patients had higher survival times and lower mortality rates than those who were not vaccinated. We think that it is important to vaccinate elderly patients and that additional doses may be needed.en_US
dc.identifier.doi10.31086/tjgeri.2022.297
dc.identifier.endpage385en_US
dc.identifier.issn1304-2947
dc.identifier.issn1307-9948
dc.identifier.issue3en_US
dc.identifier.startpage377en_US
dc.identifier.urihttps://doi.org/10.31086/tjgeri.2022.297
dc.identifier.urihttps://hdl.handle.net/11616/103925
dc.identifier.volume25en_US
dc.identifier.wosWOS:000876490100005en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherGunes Kitabevi Ltd Stien_US
dc.relation.ispartofTurkish Journal of Geriatrics-Turk Geriatri Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCOVID-19en_US
dc.subjectAgeden_US
dc.subjectCritical Careen_US
dc.subjectVaccinesen_US
dc.titlePROGNOSIS OF GERIATRIC COVID-19 PATIENTS ADMITTED TO INTENSIVE CARE UNIT ACCORDING TO VACCINATION STATUSen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu